Cramer's Lightning Round - Off Target (1/23/09)

Stocks discussed on the lightning round session of Jim Cramer's Mad Money TV Program, Friday January 23.

Bullish Calls:

Walt Disney (DIS): “Under 20 is a buy…put it away….Bob Iger is a terrific manager.”
Con Agra (CAG): “…you better go buy Con Agra. You get that accidental high yield.”
Research in Motion (RIMM): “Buy Research in Motion.”
Allscripts (MDRX): “I’d stay with MDRX which has less hospital exposure and is a more exciting situation (than The Advisory Board).”
Emergent Biosolutions (EBS): “I like it....it’s had a bit of a run…it’s a bit of a Obama play…I’d let it come down before buying.”

Bearish Calls:

MEMC Electronic (WFR): “No I gotta tell you, when it bounces, you gotta sell it…I’m reiterating I don’t like the stock.”
Cal-Maine (CALM): “I don’t know, egg play. I think you better go buy Con Agra. You get that accidental high yield.”
The Advisory Board (ABCO): “The stock’s taking a hit because its dependency on hospitals. I’d stay away from ABCO.”
International Game Technology (IGT): “I don’t’ want to buy gambling stock now… sell sell sell.”
Target (TGT): “Everyone’s suddenly jumping on Target. I don’t want that credit card business and I’m not that enamored of the Target stores. I don’t want to shop there. I don’t want to buy the stock.”
Garmin (GRMN): “You don’t want to touch that thing. It’s come all the way down and I still don’t want to buy it.”

Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightning Round and his Stop Trading! Picks.

Get Cramer's Picks by email-- it's free and takes only a few seconds to sign up.

Seeking Alpha is not affiliated with Jim Cramer, CNBC or TheStreet.com

Comments

[Victhom:]

YOU ARE SO MUCH...LOL

READ YOURSELF IN FROM OF A MIRROR???

Barclays (NYSE: BCS) (Cramer's Take) makes it? They actually didn't blow up? It's interesting to see what happens to a bank when it reports decent numbers. It can go higher.

Last week???

seekingalpha.com/artic...

SHAME ON YOU!!!

Barclays will be over $20 US in 2009 look at this graph...LOL

stockcharts.com/c-sc/s...

CRAMER SAYS SELL LOW BUY HIGH...KEEP GOING...LOL

Jan 26 01:47 PM

[Victhom:]

look at last few trades in London for Barclays JIM...the last trade was it you?? LOL

Last Trades Get Last Trades for:






PRICES

Date/Time Price Volume
Mon, Jan 26
4:35pm 88.70 p 15,353,184
4:29pm 86.30 p 913
4:29pm 86.30 p 9,087
4:29pm 86.40 p 2,678
4:29pm 86.50 p 2,400
4:29pm 86.50 p 2,413
4:29pm 86.50 p 5,822
4:29pm 86.50 p 2,178

Jan 26 01:50 PM

[look closer:]

Anyone who listens to Big Mouth is a jacka$$, plain and simple --- nearly every one of his calls is 100% wrong.

Jan 26 02:41 PM

[Anthony Alfidi:]

People like Jim Cramer will always get airtime. Egotists love attention and will compete for it at the expense of their integrity. Wall Street loves whipping investors into panicked buying and selling and will buy advertising in marketing channels whose mouthpieces (Cramer, Money Magazine) support that agenda.

Jan 26 10:08 PM

[cool hand luke:]

I took a good look at some of the "hot" stem cell companies last couple of days and here is my take.....

The hottest are GERN and STEM and these two are really a pair of jokes.....

1. They both have no real revenue and a ton of loss every year and for the foreseeable future.

2. They actually are some R&D shops with lots of patents and all their clinical trials are at very prelimary stage at least 5 years away from any commercial value if there is any.

3. Their current market value are insanely high and they all have at least a few pumping analysts and institutional writers to pump them.

4. These two are like the legal crap shooting machine, best play for day-traders.

Amazing.... no real products, no real revenue (tiny revenue from cash interest income) and a HUGE pipe dream that are being trading for hundreds of millions value.

THEREFORE:

My pick for 2009 and beyond is Thermogenesis (KOOL).

KOOL should be the 1st profitable stem cell company from operation with real product lines and revenue. No debt, plenty of cash, tons of pricing power (just raised price 25% of its products), no competition and huge market to grow for the next 10 years.

Jan 27 02:37 AM